Aminodiol HIV Protease Inhibitors. Synthesis And Structure−Activity Relationships Of P1/P1‘ Compounds: Correlation between Lipophilicity and Cytotoxicity
Journal of Medicinal Chemistry1996Vol. 39(10), pp. 1991–2007
Citations Over TimeTop 24% of 1996 papers
Ping Chen, Peter T. W. Cheng, Masud Alam, Barbara D. Beyer, Gregory S. Bisacchi, Tamara Dejneka, Adelaide J. Evans, Jill A. Greytok, Mark A. Hermsmeier, W. Griffith Humphreys, G. A. JACOBS, Octavian Kocy, Pin‐Fang Lin, Karen A. Lis, Michael A. Marella, Denis E. Ryono, Amy K. Sheaffer, Steven H. Spergel, Chong‐Qing Sun, Joseph A. Tino, Gregory D. Vite, Richard J. Colonno, Robert Zahler, Joel C. Barrish
Abstract
A series of novel aminodiol inhibitors of HIV protease based on the lead compound 1 with structural modifications at P1‘ were synthesized in order to reduce the cytotoxicity of 1. We have observed a high degree of correlation between the lipophilicity and the cytotoxicity of this series of inhibitors. It was found that appropriate substitution at the para position of the P1‘ phenyl group of 1 resulted in the identification of equipotent (both against the enzyme and in cell culture) compounds (10l, 10m, 10n, and 15c) which possess significantly decreased cytotoxicity.
Related Papers
- → Cyclic Urea Amides: HIV-1 Protease Inhibitors with Low Nanomolar Potency against both Wild Type and Protease Inhibitor Resistant Mutants of HIV(1997)114 cited
- → Pyranoxanthones: Synthesis, growth inhibitory activity on human tumor cell lines and determination of their lipophilicity in two membrane models(2013)35 cited
- → Design, synthesis and structure–activity relationship studies of novel phenoxyacetamide-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes(2015)32 cited
- → Structure-activity relationships of rationally designed AMACR 1A inhibitors(2018)12 cited
- → Lead generation and optimization of novel GPR119 agonists with a spirocyclic cyclohexane structure(2018)7 cited